Last reviewed · How we verify

NCT05292599

Effect of a Home-based Versus Supervised Exercise Program in Patients With Migraine

Completed NA Last updated 11 July 2023
What this trial tests

NA trial testing Experimental in Migraine in 40 participants. Completed in 20 June 2023.

Timeline
13 June 2022
Primary endpoint
20 June 2023
20 June 2023

Quick facts

Lead sponsorUniversity of Gran Rosario
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment40
Start date13 June 2022
Primary completion20 June 2023
Estimated completion20 June 2023
Sites1 location across Argentina

Drugs / interventions tested

Conditions studied

Sponsor

University of Gran Rosario

Who can join

Adults 18 to 55, any sex, with Migraine or Exercises. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Migraine is a common primary headache with documented impacts on the patient, the economy, and society. A growing number of studies have reported that people with migraines are more likely to experience neck pain and neck dysfunction. The coexistence of migraine and neck pain is also associated with a higher frequency of migraine attacks, greater susceptibility to certification. It has been reported that they present decreased cervical mobility, as well as decreased strength, resistance, and coordination of the cervical musculature of the skull. The objective of this study is to evaluate the possible clinical effects in migraineurs of supervised craniocervical and axioscapular exercises versus home-based exercises.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Experimental

Trials testing the same drug.

Other recruiting trials for Migraine

Currently open trials in the same condition.

Other University of Gran Rosario trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05292599.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing